IDXX
Idexx Laboratories Inc
NASDAQ · Health Care
$644.61
+1.02 (+0.16%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 4.24B | 3.91B | 11.11B | 10.62B | 11.63B |
| Net Income | 1.04B | 865.93M | 1.11B | 1.10B | 1.27B |
| EPS | — | — | — | — | — |
| Profit Margin | 24.6% | 23.4% | 10.0% | 10.3% | 10.9% |
| Rev Growth | +8.5% | +8.5% | +19.1% | +24.1% | +5.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 8.89B | 8.89B | 3.54B | 3.29B | 3.69B |
| Total Equity | 16.84B | 16.84B | 37.37B | 41.52B | 37.24B |
| D/E Ratio | 0.53 | 0.53 | 0.09 | 0.08 | 0.10 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.34B | 1.17B | 2.15B | 2.07B | 2.23B |
| Free Cash Flow | — | — | 644.55M | 651.24M | 734.03M |